Opinion leaders in the medical community attract more attention than randomized controlled trials in shoulder surgery.

Citations Conflicts of interest Impact factor Opinion leaders Randomized control trials

Journal

International orthopaedics
ISSN: 1432-5195
Titre abrégé: Int Orthop
Pays: Germany
ID NLM: 7705431

Informations de publication

Date de publication:
01 2021
Historique:
received: 31 05 2020
accepted: 11 08 2020
pubmed: 20 8 2020
medline: 22 4 2021
entrez: 20 8 2020
Statut: ppublish

Résumé

The objective of this study was to determine whether opinion leaders in the medical community attract more attention than randomized controlled trials (RCT) in shoulder surgery. A PubMed search to retrieve all therapeutic and diagnosis RCT shoulder studies was carried out. Three opinion leaders were chosen from among the last ten presidents of the European Shoulder and Elbow Society based on the number of publications. Their studies were also retrieved from PubMed. The metrics of the studies were determined through ResearchGate and Web of Science. The year of publication, impact factor of the journal, level of evidence, number of citations, number of reads, research interest, and reported conflicts of interest were recorded for every study. Two-hundred forty-five shoulder RCTs and 236 opinion leader studies met the inclusion criteria. The opinion leader studies were read significantly more times than the RCTs (p = 0.04). The mean impact factor for RCT studies was 2.84 (SD 3.9) while it was of 1.99 (SD1.14) in the opinion leader group (p < 0.001). Most of the studies of the opinion leaders were level IV (73.3%), while only 6.3% of their papers were categorized as levels I-II. Conflict of interest was present in 19.6% of the RCTs and in 32.2% of the opinion leader studies (p < 0.001). The medical community pays more attention to opinion leader studies in shoulder surgery than to RCT studies even though RCTs are published in higher impact factor journals and opinion leader studies are mainly level IV evidence studies.

Identifiants

pubmed: 32813036
doi: 10.1007/s00264-020-04775-8
pii: 10.1007/s00264-020-04775-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

33-38

Références

Lomas J, Enkin M, Anderson GM, Hannah WJ, Vayda E, Singer J (1991) Opinion leaders vs audit and feedback to implement practice guidelines. JAMA. 265:2202–2207
doi: 10.1001/jama.1991.03460170056033
Evidence-Based Medicine Working Group (1992) Evidence-based medicine: a new approach to teaching the practice of medicine. JAMA 268:2420–2425. https://doi.org/10.1001/jama.1992.03490170092032
doi: 10.1001/jama.1992.03490170092032
Cunningham BP, Harmsen S, Kweon C, Patterson J, Waldrop R, McLaren A, McLemore R (2013) Have levels of evidence improved the quality of orthopaedic research? Clin Orthop Relat Rese. 471:3679–3686. https://doi.org/10.1007/s11999-013-3159-4
doi: 10.1007/s11999-013-3159-4
OCEBM Working Group (2011) The Oxford 2011 Levels of Evidence. Oxford Centre for Evidence-Based Medicine. http://www.cebm.net/ocebm-levels-of-evidence/ . Accessed December 2019.
Jefferson L, Brealey S, Handoll H, Keding A, Kottam L, Sbizzera I, Rangan A (2017) Impact of the PROFHER trial findings on surgeon’s clinical practice. Bone Joint Res. 6:590–599. https://doi.org/10.1302/2046-3758.610.BJR-2017-0170
doi: 10.1302/2046-3758.610.BJR-2017-0170 pubmed: 29066532 pmcid: 5670363
Chimonas S, Frosch Z, Rothman DJ (2011) Form disclosure to transparency. Arch Intern Med. 171:81–86. https://doi.org/10.1001/archinternmed.2010.341
doi: 10.1001/archinternmed.2010.341 pubmed: 20837820
Zuckerman JD, Prasarn M, Kubiak EN, Koval KJ (2004) Conflict of interest in orthopaedic research. J Bone Joint Surg. 86-A:423–428. https://doi.org/10.2106/00004623-200402000-00030
doi: 10.2106/00004623-200402000-00030
Kubiak EN, Park SS, Egol K, Zuckerman JD, Koval KJ (2006) Increasingly conflicted. Bull Hosp Joint Dis 63:83–87
Shah RV, Albert TJ, Bruegel-Sanchez V, Vaccaro AR, Hilibrand AS, Grauer JN (2005) Industry support and correlation to study outcome for papers published in spine. Spine. 30(9):1099–1104
doi: 10.1097/01.brs.0000161004.15308.b4
Amiri AR, Kanesalingam K, Cro S, Casey ATH (2014) Does source of funding and conflict of interest influence the outcome and quality of spinal research? The Spine Journal. 14:308–314. https://doi.org/10.1016/j.spinee.2013.10.047
doi: 10.1016/j.spinee.2013.10.047 pubmed: 24231776
Okike K, Kocher MS, Mehlman CT, Bhandari M (2007) Conflict of interest in orthopaedic research. J Bone Joint Surg. 89-A(3):608–613. https://doi.org/10.2106/JBJS.F.00994
doi: 10.2106/JBJS.F.00994
Printz JO, Lee JJ, Knesek M, Urquhart AG (2013) Conflict of interest in the assessment of hyaluronic acid injections for ostroarthritis of the knee: an updated systematic review. J Artrhroplasty. 28(suppl 1):30–33. https://doi.org/10.1016/j.arth.2013.05.034
doi: 10.1016/j.arth.2013.05.034
Bhandari M, BusseJW JD, Montori VM, Schünemann H, Sprague S, Mears D, Schemitsch EH, Heels-Ansdell D, Devereaux PJ (2004) Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. CMAJ. 170(4):477–480
pubmed: 14970094 pmcid: 332713
Als-Nielsen B, Chen W, Gluud C, Kjaergard LL (2003) Association of funding and conclusions in randomized drug trials. JAMA. 290:921–928. https://doi.org/10.1001/jama.290.7.921
doi: 10.1001/jama.290.7.921 pubmed: 12928469
Bekelman JE, MPhil YL, Gross CP (2003) Scope and impact of financial conflicts of interest in biomedical research. JAMA. 289:454–465. https://doi.org/10.1001/jama.289.4.454
doi: 10.1001/jama.289.4.454 pubmed: 12533125
Gelberman RH, Samson D, Mirza ESK, Callaghan JJ, Pellegrini VD (2010) Orthopedic surgeons and the medical device industry. J Bone Joint Surg 92:765–777. https://doi.org/10.2106/JBJS.I.01164
doi: 10.2106/JBJS.I.01164 pubmed: 20194337
Lefaivre KA, Shadgan B, O’Brien PJ (2011) 100 most cited articles in orthopaedic surgery. Clin Orthop Relat Rese. 469:1487–1497. https://doi.org/10.1007/s11999-010-1604-1
doi: 10.1007/s11999-010-1604-1

Auteurs

Carlos Torrens (C)

Department of Orthopedics, Hospital del Mar, Parc de Salut Mar, Passeig Marítim 25-29, 08003, Barcelona, Spain. 86925@parcdesalutmar.cat.

Fernando Santana (F)

Department of Orthopedics, Hospital del Mar, Parc de Salut Mar, Passeig Marítim 25-29, 08003, Barcelona, Spain.

Joan Miquel (J)

Department of Orthopedics, Consorci Sanitari Igualada, Igualada, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH